Hadrian Szpurka

Hadrian Szpurka is an experienced professional in the diagnostics and business development sectors, currently serving as Executive Director and previously as Senior Director at Eli Lilly and Company from June 2022 to March 2024. Prior involvement includes significant research roles at Cleveland Clinic, where Szpurka contributed to the understanding of rare hematological neoplasms as a Postdoctoral Research Fellow and Research Fellow, with over 20 publications to date. Earlier experience includes a sales role at Merazet S.A. focused on laboratory equipment in Poland. Szpurka holds an MBA in Finance from the University of Indianapolis and a PhD in Translational Hematology and Hematopoiesis from the Medical University of Warsaw.